Hiroyuki Uetake

9.2k total citations · 1 hit paper
200 papers, 4.9k citations indexed

About

Hiroyuki Uetake is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hiroyuki Uetake has authored 200 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 47 papers in Cancer Research. Recurrent topics in Hiroyuki Uetake's work include Colorectal Cancer Treatments and Studies (81 papers), Genetic factors in colorectal cancer (40 papers) and Gastric Cancer Management and Outcomes (24 papers). Hiroyuki Uetake is often cited by papers focused on Colorectal Cancer Treatments and Studies (81 papers), Genetic factors in colorectal cancer (40 papers) and Gastric Cancer Management and Outcomes (24 papers). Hiroyuki Uetake collaborates with scholars based in Japan, United States and Germany. Hiroyuki Uetake's co-authors include Kenichi Sugihara, Toshiaki Ishikawa, Yoko Takagi, Satoru Iida, Megumi Ishiguro, Yoshinori Shirota, Peter V. Danenberg, Kathleen D. Danenberg, Tetsuro Higuchi and Masayuki Enomoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Hiroyuki Uetake

189 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy

2001 511 citations Yoshinori Shirota, Hiroyuki Uetake et al. Journal of Clinical Oncology profile →

Peers

Hiroyuki Uetake

ONCOL

PRM

PFM

Mai Yamauchi United States

Teresa Troiani Italy

Eiji Sunami Japan

Frank T. Kolligs Germany

Paola Ulivi Italy

Matthias P. Ebert Germany

Eduardo Vilar United States

Ferdinando De Vita Italy

Michele Orditura Italy

Xiaoyun Liao United States

Mai Yamauchi United States

Hiroyuki Uetake

3.6k ×1.5

ONCOL

1.8k ×0.9

1.2k ×0.9

1.5k ×1.4

PRM

2.0k ×2.2

PFM

Citations per year, relative to Hiroyuki Uetake Hiroyuki Uetake (= 1×) peers Mai Yamauchi

Countries citing papers authored by Hiroyuki Uetake

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Uetake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Uetake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Uetake more than expected).

Fields of papers citing papers by Hiroyuki Uetake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Uetake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Uetake. The network helps show where Hiroyuki Uetake may publish in the future.

Co-authorship network of co-authors of Hiroyuki Uetake

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Uetake. A scholar is included among the top collaborators of Hiroyuki Uetake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Uetake. Hiroyuki Uetake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uetake, Hiroyuki, Kohei Shitara, Takayuki Yoshino, et al.. (2024). Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.. Journal of Clinical Oncology. 42(16_suppl). 3507–3507. 2 indexed citations

Shida, Dai, Aya Kuchiba, Tatsuhiro Shibata, et al.. (2023). Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. Cancer Science. 114(8). 3352–3363. 3 indexed citations

Takahashi, Takao, Kazuyuki Ishida, Yasunori Emi, et al.. (2022). Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial. Cancers. 14(18). 4392–4392. 2 indexed citations

Sunami, Kuniko, Hideaki Bando, Yasushi Yatabe, et al.. (2021). Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA. Cancer Science. 112(9). 3911–3917. 19 indexed citations

Matsuyama, Takatoshi, Raju Kandimalla, Toshiaki Ishikawa, et al.. (2020). A novel mesenchymal‐associated transcriptomic signature for risk‐stratification and therapeutic response prediction in colorectal cancer. International Journal of Cancer. 147(11). 3250–3261. 6 indexed citations

Kandimalla, Raju, Feng Gao, Takatoshi Matsuyama, et al.. (2018). Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Clinical Cancer Research. 24(16). 3867–3877. 33 indexed citations

Yamada, Ichiro, Keigo Hikishima, Norio Yoshino, et al.. (2018). Colorectal carcinoma: Ex vivo evaluation using q‐space imaging; Correlation with histopathologic findings. Journal of Magnetic Resonance Imaging. 48(4). 1059–1068. 3 indexed citations

Inokuchi, Mikito, Yoko Takagi, Toshiaki Ishikawa, et al.. (2016). Cadherin 5 expression correlates with poor survival in human gastric cancer. Journal of Clinical Pathology. 70(3). 217–221. 21 indexed citations

Inokuchi, Mikito, Yoko Takagi, Sho Otsuki, et al.. (2015). Prognostic significance of PAK4 expression in gastric cancer. Journal of Clinical Pathology. 69(7). 580–585. 20 indexed citations

10.

Fukuoka, Yutaka, Hiroshi Mizushima, Mahmut Yasen, et al.. (2011). Genome-wide integrative analysis revealed a correlation between lengths of copy number segments and corresponding gene expression profile. Bioinformation. 7(6). 280–284. 3 indexed citations

11.

Shimizu, Sayaka, Satoru Iida, Megumi Ishiguro, et al.. (2010). Methylated BNIP3 gene in colorectal cancer prognosis. Oncology Letters. 1(5). 865–872. 22 indexed citations

12.

Kobayashi, Hirotoshi, Masayuki Enomoto, Tetsuro Higuchi, et al.. (2009). A Case of Cecal Cancer with Large Abdominal Wall Abscess. The Japanese Journal of Gastroenterological Surgery. 42(10). 1603–1608. 1 indexed citations

13.

Iida, Satoru, Toshiaki Ishikawa, Masamichi Yasuno, et al.. (2008). Influence of methylation of the Wnt-antagonist SFRP1 and Dkk1 on outcome in colorectal cancer is reversed by K-Ras mutation. Cancer Research. 68. 990–990. 1 indexed citations

14.

Matsuyama, Takatoshi, Tetsuro Higuchi, Hirotoshi Kobayashi, et al.. (2008). Small Intestinal Stricture Caused by Non Steroidal Anti Inflammatory Drugs: Report of Two Cases. The Japanese Journal of Gastroenterological Surgery. 41(8). 1625–1630.

15.

Hirokawa, Katsuiku, Masanori Utsuyama, Toshiaki Ishikawa, et al.. (2008). Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells. Mechanisms of Ageing and Development. 130(1-2). 86–91. 27 indexed citations

16.

Ishiguro, Megumi, Satoru Iida, Hiroyuki Uetake, et al.. (2006). Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15. Annals of Surgical Oncology. 14(5). 1752–1762. 40 indexed citations

17.

Kobayashi, Hirotoshi, Hiroyuki Uetake, Tetsuro Higuchi, Masayuki Enomoto, & Kenichi Sugihara. (2005). JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. BMC Cancer. 5(1). 26–26. 9 indexed citations

18.

Ichikawa, Wataru, Hiroyuki Uetake, Yoshinori Shirota, et al.. (2003). Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. British Journal of Cancer. 89(8). 1486–1492. 111 indexed citations

19.

Shirota, Yoshinori, Wataru Ichikawa, Hiroyuki Uetake, et al.. (2002). Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer. Annals of Surgical Oncology. 9(6). 599–603. 18 indexed citations

20.

Nihei, Zenro, et al.. (1997). Local Excision for Synchronous Multiple Gastric Cancer.. The Japanese Journal of Gastroenterological Surgery. 30(10). 2107–2111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact